Viewing Study NCT00941928

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 10:34 AM
Ignite Modification Date: 2026-03-07 @ 10:57 PM
Study NCT ID: NCT00941928
Status: TERMINATED
Last Update Posted: 2014-05-22
First Post: 2009-07-16
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Haploidentical Natural Killer (NK) Cells With Epratuzumab for Relapsed Acute Lymphoblastic Leukemia (ALL)
Sponsor: M.D. Anderson Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Leukemia View
None Pediatric Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Blood And Marrow Transplantation View
None Relapsed Acute Lymphoblastic Leukemia View
None ALL View
None Leukemia View
None Pediatrics View
None Haploidentical NK cells View
None Cyclophosphamide View
None Cytoxan View
None Neosar View
None Epratuzumab View
None Fludarabine View
None Fludarabine Phosphate View
None Fludara View
None Interleukin-2 View
None IL-2 View
None Proleukin View
None Low-dose interleukin View
None Mesna View
None Mesnex View
None Natural Killer Cells View
None NK Cells Transplant View